about
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondAcute renal injury after partial hepatectomyAcute Kidney Injury in Patients with CirrhosisHepatorenal syndrome: Update on diagnosis and treatmentRenal failure in cirrhosis: Emerging conceptsManagement options in decompensated cirrhosisHuman albumin in the management of complications of liver cirrhosisClinical review: use of renal replacement therapies in special groups of ICU patientsTreatment and management of ascites and hepatorenal syndrome: an updateRecent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapiesIntestinal permeability in a patient with liver cirrhosisAcute kidney injury and post-reperfusion syndrome in liver transplantationNonsteroidal Anti-Inflammatory Drugs and the KidneyRenal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in ratsIncorporating temporal EHR data in predictive models for risk stratification of renal function deterioration.Predictors of renal function recovery among patients undergoing renal replacement therapy following orthotopic liver transplantationNew determinants of prognosis in bacterial infections in cirrhosis.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy StudyPlasma L-cystine/L-glutamate imbalance increases tumor necrosis factor-alpha from CD14+ circulating monocytes in patients with advanced cirrhosisRenal dysfunction in patients with cirrhosis: Where do we stand?Management of cirrhotic ascitesRisk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study.Cardiorenal syndrome in acute heart failure syndromes.Renal function in hepatosplenic schistosomiasis--an assessment of renal tubular disordersHepatorenal syndrome: aetiology, diagnosis, and treatment.Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?Study on assessment of renal function in chronic liver disease.Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.Renal dysfunction in cirrhosis.Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Renal impairment in cirrhosis unrelated to hepatorenal syndromeCorticomedullary differentiation on T1-Weighted MRI: comparison between cirrhotic and noncirrhotic patients.Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.Improving survival in decompensated cirrhosisHepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study.Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
P2860
Q24633350-83193CB4-2BB9-49BC-B74D-7515CC27C875Q26740331-8ABCE881-F592-4D12-874C-7BA9C57C4928Q26775643-B4D9CE56-98CF-4868-9874-E25667693C2BQ26777608-400EAC95-CEDD-4CAA-9B98-2516F0773E61Q26785971-D00E8777-334E-4135-BBD7-3BE4130EAB4DQ26800238-586B6998-37A1-437B-94A7-50C9F4C47BA8Q26852608-C367A5C8-136E-4ED6-80AF-8D931088249FQ26853350-B7E4F584-588B-48D6-8CD1-4A9875E8F9E0Q27000268-CEA3734F-3D38-4245-AA03-5D48C8A7D8E2Q27002436-BA944A20-DAC6-4406-9133-4297385864E0Q28067113-1AB6C957-31C1-4696-AC59-FA1326DF124CQ28074228-45B782D0-411D-46D8-AA37-75E65AA7A560Q28386844-035DD8DF-4294-4E1C-B2D7-7E568DBD79A1Q28742066-2AAE76E0-4D2E-40D6-B1C3-D827AC0DCBF6Q30873485-C06D8D75-2A72-415E-A44C-A3D0CBA03E3AQ33757393-0066842C-F649-491B-A9D7-85CD7F38EFA4Q33780129-A171A843-E235-48A3-9056-F6A54F9298AEQ33805260-155F13A9-9A04-4FC1-8F7E-E672560E6155Q33999566-52495E6B-F27D-4C01-A9F5-41CC2FDA4000Q34047665-71A8D8F0-258F-4A48-BB4D-76343F1FDE60Q34475601-410C11F0-E6F0-4B47-8BEB-222C581F5DCFQ34510762-E8812E7D-71B2-41CD-AB74-F20B2F3825EEQ34665867-881A7B38-1B29-4E6B-81B7-3A840786493EQ34757548-3D8343A3-9632-4960-A1EC-A0FA1E2D85B4Q35012890-8379DAF2-2A75-4818-BBDB-322D893E30D8Q35272248-6E825711-3053-44DC-BE56-A59D09093E99Q35548556-79B68674-7A1F-40FB-8CBB-1573D61F1332Q35553310-1681C76F-52D9-4803-9143-AD59EE4F07D2Q35559713-7075CA7D-2918-4B83-8C91-DC7E873D3313Q35652638-90F5C56D-E72B-46D9-B41F-C5AA1D7A0511Q35654104-1BD7D54F-BD45-4E5C-A9E8-45BFA4AD8DF0Q35742662-92103655-F370-4BE9-97BE-5D0F0765D3E8Q35745335-9DADF0B9-E182-4513-8708-AF309491BBA5Q35778155-169C5E94-C820-4D85-B2E5-7ECE30F5ACE3Q35810852-6BACC93F-1DB3-4822-AEDE-260641C5513EQ36090423-A549AD5F-5EDE-431E-9102-76A0786F9311Q36093575-EAE9F089-8229-4F53-B9C1-C7C6D872FE9FQ36133714-588AA92C-7E4D-4E4E-8347-2A5640090CBDQ36195323-80C2395A-E71D-46F1-A76D-DE3542B7BB0FQ36208992-3205339E-C94E-48B1-9ADF-B6B8953F2C68
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Renal failure in cirrhosis.
@en
Renal failure in cirrhosis.
@nl
type
label
Renal failure in cirrhosis.
@en
Renal failure in cirrhosis.
@nl
prefLabel
Renal failure in cirrhosis.
@en
Renal failure in cirrhosis.
@nl
P356
P1476
Renal failure in cirrhosis.
@en
P2093
Pere Ginès
P304
P356
10.1056/NEJMRA0809139
P407
P577
2009-09-01T00:00:00Z